Position in GSK
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$8,320,102
-$619,463 QoQ
Shares Held
158,720
-2.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.11%
of 13F equity value
Holder Rank
#121
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clean Yield Group holds $24,144,095 across 11 Drug Manufacturers - General names. GSK ranks #1 (34.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
This page
|
158,720 | $8,320,102 | |
| 2 | JNJ |
Johnson & Johnson
|
19,963 | $5,070,003 | |
| 3 | LLY |
ELI LILLY & Co
|
3,179 | $3,812,988 | |
| 4 | AMGN |
Amgen Inc
|
5,626 | $2,037,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,182 | $1,822,387 | |
| 6 | NVO |
Novo Nordisk A S
|
25,388 | $1,217,100 | |
| 7 | ABBV |
AbbVie Inc.
|
3,891 | $979,131 | |
| 8 | AZN |
Astrazeneca PLC
|
2,950 | $559,379 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,320,102 | 158,720 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $8,939,565 | 161,978 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $7,912,947 | 161,357 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $7,069,262 | 163,792 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $6,427,699 | 167,388 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $6,938,876 | 179,114 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $6,766,130 | 200,063 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $8,328,032 | 203,719 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $8,106,714 | 210,564 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $9,107,388 | 212,442 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $7,909,752 | 213,431 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $7,530,538 | 207,739 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $7,319,208 | 205,365 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $7,050,532 | 198,160 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $6,596,761 | 187,728 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $5,822,401 | 197,839 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $8,910,626 | 208,708 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $9,326,059 | 218,288 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $9,336,566 | 215,858 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $8,004,877 | 213,598 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $8,089,283 | 207,123 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $6,461,002 | 184,575 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $55,583 | 1,540 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $56,852 | 1,540 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $61,610 | 1,540 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $57,230 | 1,540 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||